GL1X · GenesisL1 explorer

UniProt P03369

HIV-1 protease (P03369)

HIV-1 protease (UniProt P03369): 162 experimental structures on GenesisL1, 1 ligand bound. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P03369
Protein
HIV-1 protease
Experimental structures
162
Predicted models
0
Ligands
1

Structures

162 records of P03369 in the MolNFT archive: 162 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1AIDStructure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of…x-ray diffractionA, B——
1AIDStructure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of…x-ray diffractionA, B——
1B6JHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 1x-ray diffractionA, B——
1B6JHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 1x-ray diffractionA, B——
1B6KHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 5x-ray diffractionA, B——
1B6KHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 5x-ray diffractionA, B——
1B6LHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 4x-ray diffractionA, B——
1B6LHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 4x-ray diffractionA, B——
1B6MHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 6x-ray diffractionA, B——
1B6MHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 6x-ray diffractionA, B——
1B6PHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 7x-ray diffractionA, B——
1B6PHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 7x-ray diffractionA, B——
1CPIRegioselective structural and functional mimicry of peptides. design of hydrolytically stable…x-ray diffractionA, B——
1CPIRegioselective structural and functional mimicry of peptides. design of hydrolytically stable…x-ray diffractionA, B——
1D4KHIV-1 protease complexed with a macrocyclic peptidomimetic inhibitorx-ray diffractionA, B——
1D4KHIV-1 protease complexed with a macrocyclic peptidomimetic inhibitorx-ray diffractionA, B——
1D4LHIV-1 protease complexed with a macrocyclic peptidomimetic inhibitorx-ray diffractionA, B——
1D4LHIV-1 protease complexed with a macrocyclic peptidomimetic inhibitorx-ray diffractionA, B——
1F7AHow does a symmetric dimer recognize an asymmetric substrate? a substrate complex of HIV-1 protease.x-ray diffractionA, B——
1F7AHow does a symmetric dimer recognize an asymmetric substrate? a substrate complex of HIV-1 protease.x-ray diffractionA, B——
1KJ4Substrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B, C, D——
1KJ4Substrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B, C, D——
1KJ7Substrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJ7Substrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJFSubstrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJFSubstrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJGSubstrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJGSubstrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJHSubstrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KJHSubstrate shape determines specificity of recognition recognition for HIV-1 protease: analysis of…x-ray diffractionA, B——
1KZKJE-2147-HIV Protease Complexx-ray diffractionA, B——
1KZKJe-2147-HIV protease complexx-ray diffractionA, B——
1MT7Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MT7Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MT8Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MT8Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MT9Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MT9Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MTBViability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MTBViability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral…x-ray diffractionA, B——
1MTRHIV-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitorx-ray diffractionA, B——
1MTRHIV-1 protease complexed with a cyclic phe-ile-val peptidomimetic inhibitorx-ray diffractionA, B——
1N49Viability of a Drug-Resistant HIV-1 Protease Variant: Structural Insights for Better Anti-Viral…x-ray diffractionA, B, C, D——
1N49Viability of a drug-resistant HIV-1 protease variant: structural insights for better anti-viral…x-ray diffractionA, B, C, D——
1T3RHIV protease wild-type in complex with TMC114 inhibitorx-ray diffractionA, B——
1T3RHIV protease wild-type in complex with TMC114 inhibitorx-ray diffractionA, B——
1TSQCrystal structure of AP2V substrate variant of nc-P1 decamer peptide in complex with V82A/D25N…x-ray diffractionA, B——
1TSQCrystal structure of AP2V substrate variant of nc-P1 decamer peptide in complex with V82A/D25N…x-ray diffractionA, B——
1TSUCrystal structure of decamer NCP1 substrate peptide in complex with wild-type D25N HIV-1 protease…x-ray diffractionA, B——
1TSUCrystal structure of decamer NCP1 substrate peptide in complex with wild-type D25N HIV-1 protease…x-ray diffractionA, B——
1YTGSIV protease crystallized with peptide productx-ray diffractionA, B——
1YTGSIV protease crystallized with peptide productx-ray diffractionA, B——
1YTHSIV protease crystallized with peptide productx-ray diffractionA, B——
1YTHSIV protease crystallized with peptide productx-ray diffractionA, B——
1Z1HHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 3x-ray diffractionA, B——
1Z1HHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 3x-ray diffractionA, B——
1Z1RHIV-1 protease complexed with Macrocyclic peptidomimetic inhibitor 2x-ray diffractionA, B——
1Z1RHIV-1 protease complexed with macrocyclic peptidomimetic inhibitor 2x-ray diffractionA, B——
2AIDStructure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of…x-ray diffractionA, B——
2AIDStructure of a non-peptide inhibitor complexed with HIV-1 protease: developing a cycle of…x-ray diffractionA, B——

102 records more on the page itself.

Ligands

  • ACE · Acetyl group · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.